Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial

[1]  G. Schmitz,et al.  Predictors of blood loss after coronary artery bypass grafting. , 1997, Journal of cardiothoracic and vascular anesthesia.

[2]  A. Laupacis,et al.  Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.

[3]  S. Santoro,et al.  Evaluation of a New Point-of-care Test that Measures PAF-mediated Acceleration of Coagulation in Cardiac Surgical Patients , 1996, Anesthesiology.

[4]  P. Mannucci,et al.  The Effect of Desmopressin on Reducing Blood Loss in Cardiac Surgery – A Meta-Analysis of Double-Blind, Placebo-Controlled Trials , 1995, Thrombosis and Haemostasis.

[5]  M. Ray,et al.  The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  L. Horstman,et al.  Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. , 1995, Thrombosis research.

[7]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[8]  C. Naylor,et al.  Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. , 1994, The Annals of thoracic surgery.

[9]  C. Kessler,et al.  1‐deamino‐8‐D‐arginine vasopressin (DCAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass , 1994, American journal of hematology.

[10]  H. Siragy,et al.  Significant hyponatremia following DDAVP administration in a healthy adult , 1993, American journal of hematology.

[11]  P. Mannucci,et al.  Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  P. Mongan,et al.  The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. , 1992, Anesthesiology.

[13]  S. Lethagen,et al.  DDAVP‐induced enhancement of platelet retention: Its dependence on platelet‐von Willebrand Factor and the platelet receptor GP IIb/IIIa , 1992, European journal of haematology.

[14]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[15]  J. Mathew,et al.  Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. , 1991, Anesthesiology.

[16]  C. Lynch,et al.  Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis. , 1990, Circulation.

[17]  L. Harker,et al.  Bleeding complications associated with cardiopulmonary bypass. , 1990, Blood.

[18]  R. Johns.  Desmopressin is a potent vasorelaxant of aorta and pulmonary artery isolated from rabbit and rat. , 1990, Anesthesiology.

[19]  T. Andersson,et al.  Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. , 1990, Circulation.

[20]  M. Schechter,et al.  A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. , 1989, The New England journal of medicine.

[21]  D. Düren,et al.  DESMOPRESSIN AND MYOCARDIAL INFARCTION , 1989, The Lancet.

[22]  T. Bateman,et al.  Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. , 1987, Journal of the American College of Cardiology.

[23]  R. Weintraub,et al.  Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. , 1986, The New England journal of medicine.

[24]  R. Weintraub,et al.  Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery , 1986 .

[25]  L. Harker.  Bleeding after cardiopulmonary bypass. , 1986, The New England journal of medicine.

[26]  R. Montgomery,et al.  Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. , 1986, Blood.

[27]  J. Sixma,et al.  DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. , 1984, Blood.

[28]  S J Pocock,et al.  Interim analyses for randomized clinical trials: the group sequential approach. , 1982, Biometrics.

[29]  E. Spitznagel,et al.  Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. , 1994, The Journal of thoracic and cardiovascular surgery.

[30]  P. Mannucci,et al.  Desmopressin, Surgery and Thrombosis , 1994, Thrombosis and Haemostasis.